Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …

Background Valve reintervention after transcatheter aortic valve replacement (TAVR) failure
has not been studied in detail. Objectives The authors sought to determine outcomes of …

Background With increasing numbers of patients undergoing transcatheter aortic valve
replacement (TAVR), data on management of failed TAVR, including repeat TAVR …

Over a decade of randomized controlled trial data demonstrate excellent outcomes with
transcatheter aortic valve replacement or surgical aortic valve replacement for patients with …

Background The advent of transcatheter aortic valve replacement (TAVR) has directly
impacted the lifelong management of patients with aortic valve disease. The US Food and …

Aortic stenosis (AS), the most common valvular disease in the western world has been
traditionally treated with surgical aortic valve replacement (SAVR) but is increasingly treated …

Aortic stenosis (AS) contributes to significant cardiovascular morbidity and mortality
worldwide, and the natural history from symptoms to ventricular decompensation, heart …

Twenty years since the introduction of transcatheter aortic valve replacement (TAVR),
current guidelines recommend the procedure as first-line therapy for older patients with …

With broadening applications of transcatheter aortic valve replacement (TAVR) and
increasing use in intermediate-and low-risk patients, the incidence of surgical re …

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Reintervention for failed transcatheter heart valves will likely …